Y2 Solution: Q1 2026 Sales Surge but Net Loss Persists, Debt Ratio Soars

Consolidated revenue KRW 86.66 billion (YoY +128%), operating profit KRW 0.95 billion (vs KRW 0.93 billion), net loss KRW 0.65 billion (vs net profit KRW 0.78 billion)
Debt ratio skyrocketed to 84.7% (end of 2025: 49.9%), new short-term borrowings of KRW 17.5 billion (trade finance KRW 15 billion)
Credit rating downgraded from BB+ to BB0 (NICE D&B, Apr 8, 2026)
Bioenergy segment sales surged to KRW 61.43 billion (vs KRW 2.74 billion), PSU segment sales declined to KRW 24.27 billion (vs KRW 35.33 billion)
Added 5 business objectives related to robotics/AI (Mar 30, 2026), expanding collaborative robot and AMR business through subsidiary HRT Robotics (100% stake)
Accumulated deficit KRW 100.67 billion, no dividends
Derivative liability of KRW 12.14 billion related to convertible bonds (15th series, KRW 15 billion)
Embezzlement-related receivables of KRW 40.75 billion fully impaired (low recoverability)